Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity
about
Decorin: A Growth Factor Antagonist for Tumor Growth InhibitionSystemically Administered, Target Organ-Specific Therapies for Regenerative MedicineDecoding the Matrix: Instructive Roles of Proteoglycan ReceptorsBiological interplay between proteoglycans and their innate immune receptors in inflammationThe wound healing, chronic fibrosis, and cancer progression triadSystems biology-opportunities and challenges: the application of proteomics to study the cardiovascular extracellular matrixPivotal role for decorin in angiogenesisTaking aim at the extracellular matrix: CCN proteins as emerging therapeutic targetsKey roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiologySoluble biglycan as a biomarker of inflammatory renal diseases.Decorin treatment of spinal cord injuryJunctional adhesion molecule-A regulates vascular endothelial growth factor receptor-2 signaling-dependent mouse corneal wound healing.MicroRNA 181b regulates decorin production by dermal fibroblasts and may be a potential therapy for hypertrophic scar.Pathophysiological mechanisms of autosomal dominant congenital stromal corneal dystrophy: C-terminal-truncated decorin results in abnormal matrix assembly and altered expression of small leucine-rich proteoglycansThe role of the TGF-β family in wound healing, burns and scarring: a reviewThe small leucine-rich repeat proteoglycans in tissue repair and atherosclerosisDecorin as a multivalent therapeutic agent against cancer.Intracellularly-retained decorin lacking the C-terminal ear repeat causes ER stress: a cell-based etiological mechanism for congenital stromal corneal dystrophy.Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial FibrillationRole of proteoglycans in the regulation of the skeletal muscle fibrotic response.CCN2: a novel, specific and valid target for anti-fibrotic drug intervention.Wnt signaling in skeletal muscle dynamics: myogenesis, neuromuscular synapse and fibrosis.Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis.MicroRNA regulation of extracellular matrix components in the process of atherosclerotic plaque destabilization.The internal region leucine-rich repeat 6 of decorin interacts with low density lipoprotein receptor-related protein-1, modulates transforming growth factor (TGF)-β-dependent signaling, and inhibits TGF-β-dependent fibrotic response in skeletal muscUnderstanding the process of fibrosis in Duchenne muscular dystrophy.CCN2/decorin interactions: a novel approach to combating fibrosis?CCN2: a master regulator of the genesis of bone and cartilage.Targeted Antiscarring Therapy for Tissue Injuries.Small Leucine-Rich Proteoglycans in Renal Inflammation: Two Sides of the Coin.Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment.CCN4/WISP1 controls cutaneous wound healing by modulating proliferation, migration and ECM expression in dermal fibroblasts via α5β1 and TNFα.PLAP-1/Asporin Positively Regulates FGF-2 Activity.Topical Application of Adelmidrol + -Traumatic Acid Enhances Skin Wound Healing in a Streptozotocin-Induced Diabetic Mouse ModelSerum decorin is a potential prognostic biomarker in patients with acute exacerbation of idiopathic pulmonary fibrosis
P2860
Q26772197-96C01F4B-E81F-42A8-B54F-ECC48BF9796BQ26782082-EF57B723-4A33-46A6-A063-11441FFFE82AQ26801397-6D90BFA0-10DE-4C3E-8B8E-5CA7C147FBF2Q27005610-8B31D6C4-3E93-43FB-B574-FADF8707F2B6Q27014616-C3CFCFAE-64B8-484F-89D4-07E15540979BQ28066160-DD891A15-4874-4803-86A7-FAA179A6478CQ28085303-25442879-F98F-4F3F-924F-798FC2BF2A1FQ28254386-9913F01B-CFBE-468D-B5DF-6A74A48F7F56Q33819300-0B5FCA69-02D5-47DC-896A-B6640AFA472EQ34160971-BD72382B-CD0A-4E1B-83D8-F1143F05B4E1Q34412717-0DB06C2F-FF9F-4DBF-B863-EAC39277E320Q34718345-16AF9367-9595-42D3-B9B2-4694921EFDC9Q35251059-F5E667D2-7D29-4A54-97A1-D3B01015C098Q35475232-17699AD2-C7F8-4D36-9AB0-DD386DD5D8E9Q36154247-F034E3A4-1240-43F2-A41F-C0A3470C6B94Q36192960-BF3702F5-FA3B-4B0A-B9F3-8F759D9FEE66Q36578803-F213CCE5-8FE9-40D8-94DB-05EE45CBE2FCQ36986486-F89DD40E-6D03-45FF-9F40-F7BFCFA943F1Q37368108-7FD2A047-72F6-4503-9807-FB82A85B7938Q38096495-3B4ED3E0-E6B5-4D7A-93BF-CE149625DDB3Q38121157-B22A016D-E247-43BF-AA1E-BB8445F2B79BQ38135328-ED2EE170-B369-44A3-B400-15780B30FB55Q38206875-3529C6FF-D6DA-4011-A317-A0D3C126C5BBQ39261257-868E168B-244C-4D76-9E59-91F2E534CA29Q39421460-4FD00096-CD1A-4122-990B-D07D8F8F0893Q39699112-12C4BB06-8FF5-4C2D-885B-1B95DBD68FC6Q39755174-C3BA611E-703E-4327-9275-498DD4D38AD1Q43095740-E1940DD8-C7D0-461A-B0A8-AA4E6A1B58B8Q43198563-2C0FA4D5-2808-457A-840B-62E77997ADEEQ47229248-0167FC50-0EAF-40A9-8143-90D146A0962EQ50052813-058F8E48-AB26-4693-A7F5-F97E83FDB18CQ50060196-EBF0630B-171F-43AD-8EF4-BEAC44AE736DQ53396368-DA4DF7BC-2A30-46B7-A4C9-25F00BA0B6C3Q58712839-22215175-BADA-4176-A896-A9F29FA3E9D4Q58770903-3CBE349F-28AD-4EF3-A962-AE8A154919D0
P2860
Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Decorin interacts with connect ...... biting its biological activity
@ast
Decorin interacts with connect ...... biting its biological activity
@en
type
label
Decorin interacts with connect ...... biting its biological activity
@ast
Decorin interacts with connect ...... biting its biological activity
@en
prefLabel
Decorin interacts with connect ...... biting its biological activity
@ast
Decorin interacts with connect ...... biting its biological activity
@en
P2093
P2860
P356
P1476
Decorin interacts with connect ...... biting its biological activity
@en
P2093
Cristian Santander
Daniel Cabrera
Jaime Gutiérrez
P2860
P304
24242-24252
P356
10.1074/JBC.M110.189365
P407
P577
2011-03-23T00:00:00Z